tiprankstipranks
Trending News
More News >
Nordson Corp (NDSN)
NASDAQ:NDSN

Nordson (NDSN) AI Stock Analysis

Compare
376 Followers

Top Page

NDSN

Nordson

(NASDAQ:NDSN)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 5.2)
Rating:74Outperform
Price Target:
$322.00
▲(18.82% Upside)
Action:ReiteratedDate:03/05/26
The score is driven mainly by strong financial quality (durable margins and solid free cash flow) and a constructive earnings update with raised FY2026 guidance. These positives are tempered by a premium valuation and only moderate technical momentum, plus balance-sheet leverage that has risen versus prior years.
Positive Factors
High profit margins and operating profitability
Sustained gross margins near the mid-50s and low-to-mid-20s operating margins indicate durable pricing power and efficient manufacturing. High structural margins support reinvestment, return of capital, and resilience to cyclical sales swings over the next several quarters.
Strong cash generation and conversion
Robust operating and free cash flow that closely tracks net income underpins capital allocation flexibility. Consistent cash conversion funds dividends, buybacks, capex and targeted M&A without depending on new equity, strengthening long‑run financial durability.
Diversified end markets and recurring aftermarket revenue
A business model combining capital equipment with high‑margin recurring consumables and services reduces cyclical volatility. Long customer relationships, high switching costs and exposure to multiple end markets create multiple demand drivers and steady aftermarket cash flow.
Negative Factors
Rising leverage and higher debt levels
Elevated leverage and ~2x net leverage reduce financial flexibility and increase interest and covenant risk if demand softens. Higher debt limits optionality for large acquisitions or aggressive buybacks and raises refinancing exposure over the medium term.
Slowing top-line growth
Low-single-digit revenue growth makes future EPS gains more dependent on margin expansion or cost control. If mix, FX, or competitive pressure compresses margins, limited top-line momentum constrains sustainable earnings growth over coming quarters.
Margin pressure from product/geographic mix and lumpy ATS systems demand
Concentration in lower‑incremental geographies and system‑heavy ATS demand increases margin volatility and quarter-to-quarter earnings variability. Structural mix shifts and timing of large system installations can undermine margin predictability and cash flow smoothing.

Nordson (NDSN) vs. SPDR S&P 500 ETF (SPY)

Nordson Business Overview & Revenue Model

Company DescriptionNordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids worldwide. It operates through two segments, Industrial Precision Solutions (IPS) and Advanced Technology Solutions (ATS). The IPS segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems used in packaged goods industries; components and systems used in the thermoplastic melt stream; and product assembly systems for use in paper and paperboard converting applications, and manufacturing roll goods, as well as for the assembly of plastic, metal, and wood products. It also offers automated and manual dispensing products and systems to apply adhesive and sealant materials; dispensing and curing systems to coat and cure containers; systems to apply liquid paints and coatings to consumer and industrial products; and systems to apply powder paints and coatings to metal, plastic, and wood products, as well as ultraviolet equipment for use in curing and drying operations for specialty coatings, semiconductor materials, and paints. The ATS segment provides automated dispensing systems for the attachment, protection, and coating of fluids, as well as related gas plasma treatment systems for cleaning and conditioning surfaces; precision manual and semi-automated dispensers, minimally invasive interventional delivery devices, plastic molded syringes, cartridges, tips, fluid connection components, tubing, balloons, and catheters; and bond testing and automated optical, acoustic microscopy, and x-ray inspection systems for use in semiconductor and printed circuit board industries. The company markets its products through direct sales force, as well as distributors and sales representatives. Nordson Corporation was founded in 1935 and is headquartered in Westlake, Ohio.
How the Company Makes MoneyNordson generates revenue primarily through the sale of its advanced equipment and systems, which are utilized in a wide range of industrial applications. Key revenue streams include the sale of dispensing equipment, surface treatment solutions, and other manufacturing technologies. The company also earns income from service contracts and aftermarket parts, which provide ongoing support and maintenance for its products. Significant partnerships with leading companies in various industries enhance Nordson's market reach and foster innovation, while its focus on R&D helps in developing new technologies that meet evolving customer needs. Additionally, Nordson's global presence allows it to tap into diverse markets, contributing to its overall revenue growth.

Nordson Key Performance Indicators (KPIs)

Any
Any
Sales by Segment
Sales by Segment
Breaks down revenue generated by each business segment, indicating which areas are driving growth and which may need strategic adjustments.
Chart InsightsNordson's Industrial Precision and Medical & Fluid segments are showing resilience, with the latter experiencing a notable 10% growth, supported by organic sales and successful integration of Atrion Medical. However, the Advanced Technology segment faces challenges, with a 4% sales decline due to weak x-ray systems demand. Despite these mixed results, Nordson's robust cash flow and strategic share repurchases position it well for future growth, as reflected in their optimistic 2026 guidance. The absence of sales in Adhesive Dispensing and Industrial Coating segments remains a concern.
Data provided by:The Fly

Nordson Earnings Call Summary

Earnings Call Date:Feb 18, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:May 25, 2026
Earnings Call Sentiment Positive
The call conveyed a strong start to fiscal 2026 with record sales, record adjusted EPS and EBITDA, robust ATS momentum, healthy free cash flow and an upward revision to full-year guidance. Offsetting items include margin headwinds from geographic/product mix and FX, a slower start in Medical partly due to weather and a prior divestiture, and inherent lumpiness in ATS system demand. On balance, operational execution, cash generation and raised guidance outweigh the manageable challenges.
Q1-2026 Updates
Positive Updates
Record First Quarter Sales
Q1 sales reached a record $669 million, up 9% year-over-year (prior year $615 million); organic sales up 7% driven by strong demand in Asia.
Robust Advanced Technology Solutions (ATS) Performance
ATS sales of $149 million, a 23% increase year-over-year (21% organic growth); segment EBITDA rose 43% to $33 million and margin improved to 22% driven by double-digit electronics dispense growth and recovering X-ray demand.
Profitability Records and Margin Resilience
Adjusted operating profit increased 10% to $166 million; EBITDA was a Q1 record of $203 million, up 8%, with consolidated EBITDA margin around 30% (in line with prior year). Adjusted EPS was a Q1 record of $2.37, up 15% from $2.06.
Strong Free Cash Flow and Capital Deployment
Free cash flow of $123 million in the quarter with cash conversion at 105% of net income (excluding non-cash gain). Company returned capital via $46 million dividends and $82 million share repurchases, while investing $18 million in capex.
Improved Guidance and Backlog Momentum
Backlog up ~4% year-over-year entering Q2. Q2 sales guidance $710–$740 million and adjusted EPS $2.70–$2.90. Full-year guidance raised to $2.86–$2.98 billion (midpoint +4.5%) and adjusted EPS $11–$11.60 (midpoint +10%).
Balance Sheet Strength and Leverage Management
Cash on hand $120 million, net debt ~$1.9 billion, and leverage ratio 2.1x (consistent with year-end targets). New credit facility provides ~ $800 million available capacity and financial flexibility for strategic M&A.
One-time Non-Cash Investment Gain Recognized Separately
A $22 million pre-tax non-cash mark-to-market gain from a minority investment (post-IPO) was recorded in other income and excluded from adjusted earnings.
Negative Updates
Geographic and Product Mix Pressures on Margins
Sales growth concentrated in Asia, where gross margins are generally lower (notably on system sales), resulting in lower incrementals for the quarter and a 2% decline in IPS EBITDA margin to 34% of sales compared with prior year.
Medical & Fluid Solutions Slow Start and Weather Disruption
MFS sales of $193 million were relatively flat year-over-year; organic sales up 3% but hampered by a ~4% divestiture impact. Severe winter storms late in January temporarily reduced production and deliveries, estimated to have trimmed ~1% from quarterly sales.
Divestiture Impact on Comparables
The prior-quarter divestiture of the medical contract manufacturing business reduced comparable sales by about 4%, affecting year-over-year growth comparisons and segment-level metrics.
Foreign Exchange Incremental Drag
Favorable currency translation added ~4% to top-line and ~6% to IPS sales, but FX uplift carries lower incrementals (company cites a 25%–30% incremental for FX moves), reducing margin leverage in the quarter.
ATS Lumpy Systems Demand and Timing Risk
ATS is system-heavy and thus inherently lumpy; results depend on customer installation timing and can produce quarter-to-quarter variability despite strong underlying demand and backlog.
Company Guidance
Nordson raised its fiscal‑2026 outlook off a strong start — record Q1 sales of $669 million (up 9% YoY, 7% organic), backlog +~4% YoY and $123 million of free cash flow — and now guides Q2 sales of $710–$740 million with Q2 adjusted EPS of $2.70–$2.90; full‑year sales are pegged at $2.86–$2.98 billion (midpoint +4.5%) and full‑year adjusted EPS at $11.00–$11.60 (midpoint +10%), with management still projecting a full‑year effective tax rate at the lower end of the prior 18.5%–19.5% range; the high end of the range assumes continued electronics/ATS momentum plus modest industrial/auto improvement, while the low end reflects potential broader end‑market pullbacks.

Nordson Financial Statement Overview

Summary
High-quality profitability and cash generation (gross margins ~54–56%, EBIT margins low-to-mid 20s; TTM operating cash flow ~$700M and free cash flow ~$646M with solid cash conversion). Offsetting risks are slowing revenue growth to low single digits and higher leverage versus prior years (debt-to-equity rising to ~0.64–0.79), which reduces flexibility in a softer cycle.
Income Statement
84
Very Positive
NDSN shows consistently strong profitability with solid gross margins (~54–56%) and healthy operating profitability (EBIT margin generally in the low-to-mid 20s). Net margins remain attractive (roughly ~17–20%), and TTM (Trailing-Twelve-Months) net income is solid at ~$523M. The key weakness is growth: revenue has decelerated to low single digits in recent annual periods, which makes earnings quality more dependent on margin discipline than top-line expansion.
Balance Sheet
70
Positive
The balance sheet is generally sound with steady equity and solid returns on equity (mid-teens in recent periods; ~16% in TTM (Trailing-Twelve-Months)). Leverage, however, has risen versus earlier years: debt-to-equity moved from ~0.38–0.44 (2021–2022) to ~0.64–0.79 (2023–TTM), increasing financial risk and reducing flexibility if demand softens.
Cash Flow
78
Positive
Cash generation is strong: TTM (Trailing-Twelve-Months) operating cash flow is ~$700M and free cash flow is ~$646M, with free cash flow close to net income (TTM free cash flow to net income ~0.92), supporting earnings quality. That said, free cash flow growth has been choppy and slightly negative in TTM (Trailing-Twelve-Months), and cash flow coverage of net income varies by year, pointing to some variability in working capital or cash conversion.
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue2.85B2.79B2.69B2.63B2.59B2.36B
Gross Profit1.57B1.54B1.49B1.43B1.43B1.32B
EBITDA913.91M874.79M810.58M786.74M771.62M703.55M
Net Income523.20M484.47M467.28M487.49M513.10M454.37M
Balance Sheet
Total Assets5.96B5.92B6.00B5.25B3.82B3.79B
Cash, Cash Equivalents and Short-Term Investments120.39M108.44M115.95M115.68M163.46M299.97M
Total Debt2.14B2.16B2.40B1.96B951.22M1.05B
Total Liabilities2.85B2.87B3.07B2.65B1.53B1.63B
Stockholders Equity3.11B3.04B2.93B2.60B2.29B2.16B
Cash Flow
Free Cash Flow646.31M661.12M491.78M606.70M461.70M507.62M
Operating Cash Flow700.48M719.17M556.19M641.28M513.13M545.93M
Investing Cash Flow-30.09M-26.69M-844.40M-1.44B-222.76M-33.17M
Financing Cash Flow-691.09M-706.43M294.50M750.51M-416.01M-422.91M

Nordson Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price271.00
Price Trends
50DMA
277.98
Negative
100DMA
256.56
Positive
200DMA
238.11
Positive
Market Momentum
MACD
-3.42
Positive
RSI
39.46
Neutral
STOCH
18.40
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NDSN, the sentiment is Neutral. The current price of 271 is below the 20-day moving average (MA) of 282.94, below the 50-day MA of 277.98, and above the 200-day MA of 238.11, indicating a neutral trend. The MACD of -3.42 indicates Positive momentum. The RSI at 39.46 is Neutral, neither overbought nor oversold. The STOCH value of 18.40 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NDSN.

Nordson Risk Analysis

Nordson disclosed 25 risk factors in its most recent earnings report. Nordson reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Nordson Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
82
Outperform
$14.33B26.5920.38%1.32%2.85%3.09%
78
Outperform
$16.18B28.2317.85%0.79%8.01%2.67%
77
Outperform
$14.16B25.9412.11%1.56%7.09%-2.29%
74
Outperform
$15.12B28.7117.30%1.64%3.78%4.85%
65
Neutral
$10.18B28.9319.12%0.49%-0.37%21.77%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
60
Neutral
$12.04B50.026.19%5.52%9.03%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NDSN
Nordson
271.00
65.44
31.84%
GNRC
Generac Holdings
205.18
71.51
53.50%
GGG
Graco
86.65
4.24
5.14%
IEX
IDEX
190.39
8.65
4.76%
ITT
ITT
188.00
52.31
38.55%
CR
Crane Company
176.51
22.40
14.53%

Nordson Corporate Events

Executive/Board ChangesShareholder Meetings
Nordson Shareholders Approve Directors, Auditor and Executive Pay
Positive
Mar 4, 2026

At its 2026 annual meeting held on March 2, 2026, Nordson shareholders representing 91.66% of outstanding shares voted, ensuring a quorum for the session. Shareholders elected Christopher Mapes, Michael Merriman Jr. and Sundaram Nagarajan to the board of directors to serve until the 2029 annual meeting, reinforcing continuity in the company’s governance.

Investors also ratified Ernst & Young LLP as Nordson’s independent auditor for the fiscal year ending Oct. 31, 2026, signaling support for the firm’s financial oversight. In addition, shareholders approved on an advisory, non‑binding basis the compensation of the company’s named executive officers, indicating broad backing for current executive pay practices.

The most recent analyst rating on (NDSN) stock is a Buy with a $325.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Nordson Posts Record Q1 Results, Raises 2026 Guidance
Positive
Feb 18, 2026

Nordson Corporation reported record first-quarter fiscal 2026 results on February 18, 2026, with sales rising 9% year over year to $669 million, driven by 7% organic growth and favorable currency, and net income climbing to $133 million, or $2.38 per diluted share. Adjusted earnings per share reached a first-quarter record of $2.37, backlog increased about 4%, all segments delivered organic growth led by Advanced Technology Solutions’ 23% sales gain, and management raised both second-quarter and full-year 2026 sales and adjusted earnings guidance, signaling growing confidence in demand, particularly in semiconductor and electronics end markets.

The most recent analyst rating on (NDSN) stock is a Buy with a $312.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Nordson Expands Multicurrency Revolving Credit Facility to 2031
Positive
Feb 2, 2026

On January 30, 2026, Nordson Corporation entered into an amended and restated senior unsecured multicurrency revolving credit agreement, replacing its June 6, 2023 facility and establishing a $1.2 billion revolving credit line maturing on January 30, 2031. The agreement, arranged with Wells Fargo as administrative agent and a syndicate of global lenders, allows borrowings in multiple major currencies, includes sub-facilities for standby letters of credit and swingline loans, and is governed by customary covenants tied to leverage and interest coverage ratios, as well as standard events of default. Interest rates under the facility are indexed to base or benchmark rates such as SOFR, EURIBOR, TIBOR, SORA, SONIA or SARON plus a margin based on Nordson’s leverage or debt rating, with proceeds available for working capital, acquisitions, and general corporate purposes, including refinancing existing debt. At closing, Nordson used part of the new facility to repay and retire $248 million of outstanding term loans under its prior credit arrangement, enhancing its financial flexibility and extending its debt maturity profile.

The most recent analyst rating on (NDSN) stock is a Buy with a $311.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Nordson Reports Record Q4 and Fiscal 2025 Results
Positive
Dec 10, 2025

Nordson Corporation reported record results for the fourth quarter and fiscal year 2025, with sales reaching $752 million in the fourth quarter and $2.8 billion for the full year, marking a 1% and 4% increase respectively over the prior year. The company achieved a 9% increase in adjusted earnings per share for the fourth quarter and a 5% increase for the full year, reflecting strong operational performance despite challenges such as the divestiture of its medical contract manufacturing business. Looking ahead to fiscal 2026, Nordson forecasts sales between $2,830 to $2,950 million and adjusted earnings per share ranging from $10.80 to $11.50, driven by its strategic growth framework and strong backlog.

The most recent analyst rating on (NDSN) stock is a Buy with a $285.00 price target. To see the full list of analyst forecasts on Nordson stock, see the NDSN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 05, 2026